Page last updated: 2024-08-24

gemcitabine and buthionine sulfoximine

gemcitabine has been researched along with buthionine sulfoximine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Han, H; Ji, J; Jin, Q; Wang, Y	1
Cianflone, E; Cilurzo, F; Cristiano, MC; Da Pian, M; Paolino, D; Pasut, G; Quintieri, L	1

Other Studies

2 other study(ies) available for gemcitabine and buthionine sulfoximine

Article	Year
The rational design of a gemcitabine prodrug with AIE-based intracellular light-up characteristics for selective suppression of pancreatic cancer cells. Chemical communications (Cambridge, England), 2015, Dec-21, Volume: 51, Issue:98 Topics: Amino Acid Sequence; Antineoplastic Agents; Buthionine Sulfoximine; Cathepsin B; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Deoxycytidine; Dipeptides; Endocytosis; Fluorescent Dyes; Gemcitabine; Glutathione; Humans; Integrin alphaVbeta3; Oxidation-Reduction; Pancreatic Neoplasms; Prodrugs	2015
Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine. Anti-cancer agents in medicinal chemistry, 2019, Volume: 19, Issue:12 Topics: A549 Cells; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Proliferation; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Folate Receptors, GPI-Anchored; Folic Acid; Gemcitabine; HeLa Cells; Humans; Molecular Structure; Polyethylene Glycols; Structure-Activity Relationship; Tumor Cells, Cultured	2019

Article

Year

The rational design of a gemcitabine prodrug with AIE-based intracellular light-up characteristics for selective suppression of pancreatic cancer cells.

Chemical communications (Cambridge, England), 2015, Dec-21, Volume: 51, Issue:98

Topics: Amino Acid Sequence; Antineoplastic Agents; Buthionine Sulfoximine; Cathepsin B; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Deoxycytidine; Dipeptides; Endocytosis; Fluorescent Dyes; Gemcitabine; Glutathione; Humans; Integrin alphaVbeta3; Oxidation-Reduction; Pancreatic Neoplasms; Prodrugs

2015

Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine.

Anti-cancer agents in medicinal chemistry, 2019, Volume: 19, Issue:12

Topics: A549 Cells; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Proliferation; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Folate Receptors, GPI-Anchored; Folic Acid; Gemcitabine; HeLa Cells; Humans; Molecular Structure; Polyethylene Glycols; Structure-Activity Relationship; Tumor Cells, Cultured

2019